Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
27,502,473
-
Share change
-
+1,548,509
-
Total reported value
-
$83,329,939
-
Put/Call ratio
-
0.37%
-
Price per share
-
$3.03
-
Number of holders
-
47
-
Value change
-
+$4,920,713
-
Number of buys
-
26
-
Number of sells
-
17
Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q4 2022
As of 31 Dec 2022,
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,502,473 shares.
The largest 10 holders included
BVF INC/IL, NEA Management Company, LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, FIRST MANHATTAN CO, RENAISSANCE TECHNOLOGIES LLC, and TWO SIGMA INVESTMENTS, LP.
This page lists
47
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.